Casey Logan MBA, BSE

Mr. Logan joined TRACON as Chief Business Officer in February 2013. Prior to joining TRACON, Mr. Logan led corporate development efforts at RuiYi, Inc. (formerly Anaphore) including establishment of the company’s operations in Shanghai, China. From 2007 to 2010, Mr. Logan led corporate development and strategic planning efforts at Anadys Pharmaceuticals (acquired by Roche).

From 2001 to 2007, he was with Eli Lilly and Company in Indianapolis, IN, in the corporate business development group. During his career, Mr. Logan has led transactions in both in-licensing and out-licensing of assets across a range of therapeutic areas, including the creation of two startup companies. Prior to Lilly, Mr. Logan was an officer in the US Naval Nuclear Propulsion Program. Mr. Logan received his M.B.A. from the Kellogg School of Management at Northwestern University and B.S.E. in Chemical Engineering from the University of Michigan.